Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)

NCT06251492 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Metastatic
Castration-resistant Prostate Cancer

Interventions

RADIATION: Stereotactic body radiotherapy
DRUG: Adebrelimab

Sponsor

Fudan University